The use of sacubitril/valsartan appears feasible and safe in recipients of left ventricular assist devices, reducing the need ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...

Although lowering drug costs is one of the few issues uniting almost all Americans, the president has done little to ...

Pfizer's stock has been trading at low levels for a while. Diminished growth and concerns about the future have investors ...

Vertex should earn other important approvals through 2030 that could jolt its stock price. It's developing a treatment called ...

Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that ...

Now, it’s worth noting Stock Advisor’s total average return is 1,033% — a market-crushing outperformance compared to 193 % ...

BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint ...

Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

President Donald Trump’s new partnership with Pfizer to sell drugs directly to consumers is being cast as a major ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting an observational cohort study titled ‘Treating ...

Pfizer (PFE) offers potential 20-30% upside despite revenue risks. Explore its valuation, pipeline prospects, and dividend ...